Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 2/20 | 0.56 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | GSR | P00390 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.45 |
| ▸ | GRM8 | O00222 | 1/20 | 0.45 |
| ▸ | GRM6 | O15303 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.45 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.45 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.45 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5322808 | 0.81 | SLC7A5 (0.58) | BHMTKMT2APMP22ALOX15BLM | |
| SCHEMBL6663362 | 0.81 | SLC7A5 (0.58) | BHMTKMT2APMP22ALOX15BLM | |
| SCHEMBL14445570 | 0.80 | BHMT (0.48) | BHMTCYP1A2 | |
| SCHEMBL5034721 | 0.78 | BHMT (0.60) | BHMTBHMT2KMT2APMP22ALOX15 | |
| SCHEMBL2417361 | 0.78 | BHMT (0.60) | BHMTBHMT2KMT2APMP22ALOX15 | |
| SCHEMBL1666990 | 0.78 | BHMT (0.60) | BHMTBHMT2KMT2APMP22ALOX15 | |
| SCHEMBL16574737 | 0.78 | BHMT (0.60) | BHMTBHMT2KMT2APMP22ALOX15 | |
| SCHEMBL1199780 | 0.78 | BHMT (0.60) | BHMTBHMT2KMT2APMP22ALOX15 | |
| SCHEMBL7071560 | 0.78 | SLC1A3 (0.38) | BHMTBHMT2BLMSLC1A3SLC1A2 | |
| SCHEMBL19368040 | 0.78 | SLC1A3 (0.38) | BHMTBHMT2BLMSLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | BHMT 4764/4885BHMT2 4817/4885KMT2A 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.